BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 31531526)

  • 1. lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells by sponging miR-9-5p to upregulate SOX11.
    Liu Z; Chen JY; Zhong Y; Xie L; Li JS
    Braz J Med Biol Res; 2019; 52(10):e8631. PubMed ID: 31531526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA matrilineal expression gene 3 inhibits hepatocellular carcinoma progression by targeting microRNA-5195-3p and regulating the expression of forkhead box O1.
    Li M; Liao H; Wu J; Chen B; Pang R; Huang J; Zhu Y
    Bioengineered; 2021 Dec; 12(2):12880-12890. PubMed ID: 34895065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA CYTOR affects the proliferation, cell cycle and apoptosis of hepatocellular carcinoma cells by regulating the miR-125b-5p/KIAA1522 axis.
    Hu B; Yang XB; Yang X; Sang XT
    Aging (Albany NY); 2020 Dec; 13(2):2626-2639. PubMed ID: 33318318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.
    Wu YH; Yu B; Chen WX; Ai X; Zhang W; Dong W; Shao YJ
    Aging (Albany NY); 2021 Aug; 13(15):19260-19271. PubMed ID: 34341185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between lncRNA DANCR and miR-125b-5p in HCC cell progression.
    Yang L; Jiang MN; Liu Y; Wu CQ; Liu H
    Tumori; 2021 Dec; 107(6):504-513. PubMed ID: 33272103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SNHG7 Facilitates Hepatocellular Carcinoma Occurrence by Sequestering miR-9-5p to Upregulate CNNM1 Expression.
    Xie Y; Wang Y; Gong R; Lin J; Li X; Ma J; Huo L
    Cancer Biother Radiopharm; 2020 Dec; 35(10):731-740. PubMed ID: 32397799
    [No Abstract]   [Full Text] [Related]  

  • 7. LncRNA CASC9 promotes proliferation, migration and inhibits apoptosis of hepatocellular carcinoma cells by down-regulating miR-424-5p.
    Yao J; Fu J; Liu Y; Qu W; Wang G; Yan Z
    Ann Hepatol; 2021; 23():100297. PubMed ID: 33346094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC00205, a YY1-modulated lncRNA, serves as a sponge for miR-26a-5p facilitating the proliferation of hepatocellular carcinoma cells by elevating CDK6.
    Cheng T; Yao Y; Zhang S; Zhang XN; Zhang AH; Yang W; Hou CZ
    Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6208-6219. PubMed ID: 34730201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p/FOXD1/VEGF-A axis.
    Sun DS; Guan CH; Wang WN; Hu ZT; Zhao YQ; Jiang XM
    Microvasc Res; 2021 Mar; 134():104120. PubMed ID: 33309645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
    Fei X; Zhang P; Pan Y; Liu Y
    Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA FGD5-AS1 functions as an oncogene to upregulate GTPBP4 expression by sponging miR-873-5p in hepatocellular carcinoma.
    Zhang N; Shen H; Huang S; Wang F; Liu H; Xie F; Jiang L; Chen X
    Eur J Histochem; 2021 Nov; 65(4):. PubMed ID: 34783233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA SNHG14 promotes hepatocellular carcinoma progression by regulating miR-876-5p/SSR2 axis.
    Liao Z; Zhang H; Su C; Liu F; Liu Y; Song J; Zhu H; Fan Y; Zhang X; Dong W; Chen X; Liang H; Zhang B
    J Exp Clin Cancer Res; 2021 Jan; 40(1):36. PubMed ID: 33485374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRNDE-h transcript/miR-136-5p axis regulates interleukin enhancer binding factor 2 expression to promote hepatocellular carcinoma cell proliferation.
    Shiu TY; Lin HH; Shih YL; Feng AC; Huang HH; Huang TY; Hsieh CB; Chang WK; Hsieh TY
    Life Sci; 2021 Nov; 284():119708. PubMed ID: 34153299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA-POIR promotes epithelial-mesenchymal transition and suppresses sorafenib sensitivity simultaneously in hepatocellular carcinoma by sponging miR-182-5p.
    Chen BW; Zhou Y; Wei T; Wen L; Zhang YB; Shen SC; Zhang J; Ma T; Chen W; Ni L; Wang Y; Bai XL; Liang TB
    J Cell Biochem; 2021 Jan; 122(1):130-142. PubMed ID: 32951268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA KCNQ1OT1 inhibits the radiosensitivity and promotes the tumorigenesis of hepatocellular carcinoma via the miR-146a-5p/ACER3 axis.
    Yang G; Zhou L; Xu Q; Meng F; Wan Y; Meng X; Wang L; Zhang L
    Cell Cycle; 2020 Oct; 19(19):2519-2529. PubMed ID: 32936716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA highly upregulated in liver cancer promotes the progression of hepatocellular carcinoma and attenuates the chemosensitivity of oxaliplatin by regulating miR-383-5p/vesicle-associated membrane protein-2 axis.
    Li P; Li Y; Ma L
    Pharmacol Res Perspect; 2021 Aug; 9(4):e00815. PubMed ID: 34223709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis.
    Huang C; Li K; Huang R; Zhu J; Yang J
    Life Sci; 2021 Feb; 267():118928. PubMed ID: 33358902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel role of LINC01013/miR-6795-5p/FMNL3 axis in the regulation of hepatocellular carcinoma stem cell features.
    Wang W; Xu S; Di Y; Zhang Z; Li Q; Guo K; Lv Y; Wang B
    Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):652-662. PubMed ID: 33847733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA LOC107985656 represses the proliferation of hepatocellular carcinoma cells through activation of the tumor-suppressive Hippo pathway.
    Zeng Y; Xu Q; Xu N
    Bioengineered; 2021 Dec; 12(1):7964-7974. PubMed ID: 34565286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA ZEB1-AS1 regulates hepatocellular carcinoma progression by targeting miR-23c.
    Xue S; Lu F; Sun C; Zhao J; Zhen H; Li X
    World J Surg Oncol; 2021 Apr; 19(1):121. PubMed ID: 33865414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.